29050-11-1|Seclazone|2H,9H-Isoxazolo(3,2-b)(1,3)benzoxazin-9-one, 3,3a-dihydro-7-chloro-|-范德生物科技公司

Seclazone

NMR下载 COA and HPLC MSDS下载
names：
2H,9H-Isoxazolo(3,2-b)(1,3)benzoxazin-9-one, 3,3a-dihydro-7-chloro-
CAS号：
29050-11-1
MDL Number：
MF(分子式)： C10H8ClNO3 MW(分子量)： 225.628
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	2H,9H-Isoxazolo(3,2-b)(1,3)benzoxazin-9-one, 3,3a-dihydro-7-chloro-
英文别名	Seclazone; W-2354; W 2354; W2354; W 2352;
CAS号	29050-11-1
Inchi	InChI=1S/C10H8ClNO3/c11-6-1-2-8-7(5-6)10(13)12-9(15-8)3-4-14-12/h1-2,5,9H,3-4H2
InchiKey	XWXVKXXKKLBDDJ-UHFFFAOYSA-N
分子式 Formula	C10H8ClNO3
分子量 Molecular Weight	225.628
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Seclazone(CAS:29050-11-1):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Seclazone is a biochemical.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Viaje A, Slaga TJ, Wigler M, Weinstein IB. Effects of antiinflammatory agents on mouse skin tumor promotion, epidermal DNA synthesis, phorbol ester-induced cellular proliferation, and production of plasminogen activator. Cancer Res. 1977 May;37(5):1530-6. PubMed PMID: 856468.

[2]Slaga TJ, Viaje A, Bracken W. The effects of anti-inflammatory agents on skin tumor initiation and aryl hydrocarbon hydroxylase. Res Commun Chem Pathol Pharmacol. 1977 Feb;16(2):337-50. PubMed PMID: 847288.

[3] Edelson J, Schuster EB, Douglas JF. Optimal conditions for the hydrolysis of seclazone by rat hepatic microsomes. Arch Int Pharmacodyn Ther. 1974 Sep;211(1):99-106. PubMed PMID: 4218724.

[4] Edelson J, Schuster E, Shahinian S, Douglas JF. The metabolic fate of seclazone in man. Arch Int Pharmacodyn Ther. 1974 May;209(1):66-74. PubMed PMID: 4416360.

[5] Edelson J, Douglas JF, Ludwig BJ. Seclazone: biotransformation during absorption in the rat, binding in plasma, and disappearance from plasma in the dog. Drug Metab Dispos. 1973 Nov-Dec;1(6):737-41. PubMed PMID: 4156294.

6: Edelson J, Douglas JF, Ludwig BJ. Absorption, distribution, and metabolic fate of seclazone (7-chloro-3,3a-dihydro-2H,9H-isoxazolo(3,2-b) (1,3)benzoxazin-9-one). J Pharm Sci. 1973 Feb;62(2):229-32. PubMed PMID: 4631323.7: Edelson J, Douglas JF. Measurement of gastrointestinal blood loss in the rat: the effect of aspirn, phenylbutazone and seclazone. J Pharmacol Exp Ther. 1973 Feb;184(2):449-52. PubMed PMID: 4540048.8: Hrdina PD, Ling GM. The in vivo antibradykinin activity of seclazone (7-chloro-3,3a-dihydro-2H,9H-isoxazolo(3,2-b) (1,3)benzoxazin-9-one), a new anti-inflammatory agent. Pharmacology. 1973;10(3):136-42. PubMed PMID: 4761775.9: Berger FM, Bates HM, Diamantis W, Kletzkin M, Plekss OJ, Sofia RD, Spencer HJ. The pharmacological properties of seclazone (7-chloro-3,3a-dihydro-2H, 9H-isoxazolo (3,2-b) (1,3) benzoxazin-9-one) a new anti-inflammatory agent. Pharmacology. 1973;9(3):164-76. PubMed PMID: 4714232.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开